Madrigal Pharmaceuticals(MDGL) - 2024 Q4 - Earnings Call Transcript

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Tina Ventura - Chief Investor Relations Officer Bill Sibold - CEO, President & Director Mardi Dier - CFO & Senior VP Michael Charlton - Head of Clinical Development Conference Call Participants Thomas Smith - Leerink Partners Andrea Newkirk - Goldman Sachs Yasmeen Rahimi - Piper Sandler Ellie Merle - UBS Amy Li - Jefferies Liisa Bayko - Evercore ISI David Lebowitz - Citi Andy Chen ...